Vaccination Communication Strategies and Uptake in Africa: A Systematic Review Authors: Winifred Ekezie, Beauty Igein, Jomon Varughese, Ayesha Butt, Blessing Onyinye Ukoha-Kalu, Ifunanya Ikhile, Genevieve Bosah, Pedro Plans-Rubió Published: 2024 ABSTRACT AbstractBackground: African countries experience high rates of infectious diseases that are mostly preventable by vaccination. Despite the risks of infections and other adverse outcomes, vaccination coverage in the African region remains significantly low. Poor vaccination knowledge is a contributory factor, and effective communication is crucial to bridging the vaccination uptake gap. This review summarises vaccination communication strategies adopted across African countries and associated changes in vaccine uptake. Methods: A systematic search was conducted in five bibliographic databases between 2000 and 2023 and supplemented with an additional Google Scholar search. Studies with data on vaccination communication and uptake in the English language were considered. A narrative synthesis was performed, and findings were presented in text and tables. Findings: Forty-one studies from fourteen African countries met the inclusion criteria. Several communication strategies were implemented for 13 different vaccines, mainly childhood vaccines. Mass campaigns and capacity building were the most common strategies for the public and health workers, respectively. Community-based strategies using social mobilisation effectively complemented other communication strategies.Overall, vaccination uptake increased in all countries following vaccination communication interventions. Barriers and facilitators to optimising vaccination communication at systemic and individual levels were also identified. Key barriers included lack of vaccine information, access issues, and high cost, while facilitators included improved vaccine education, reminders, trust-building initiatives, and community involvement. Conclusions: This review highlights effective vaccination communication strategies implemented across Africa as well as systemic and individual barriers and facilitators influencing vaccination uptake. The findings can inform strategies for vaccination communication and campaign planning to improve vaccination coverage in Africa.Keywords: Africa, vaccination, communication, information, views and practices, barriers and facilitators 1. Introduction Africa has one of the highest rates of infectious disease burdens, with several emerging and re-emerging infections in the 21st century [1]. Between 2001 and 2022, more than 1500 public health emergencies, predominantly involving emerging infectious diseases, were reported, underscoring the critical need for effective and efficient prevention and management actions, such as vaccination [2]. Vaccination remians one of the most effective and cost-efficient public health interventions, preventing about 5 million deaths annually [3]. However, despite the advances in vaccine development, millions still do not access vaccination services in the African region. Hence, Africa lags behind in meeting the 2030 global immunisation targets, with approxomately 12 million children missing one or more vaccinations between 2019 and 2021 [4,5]. Vaccination efforts in Africa face by numerous systemic and individual challenges [6,7]. Systemic issues in supply and delivery include logistic difficulties such as maintaining the cold chain, transportation, and stock monitoring; inadequate coordination among stakeholders; and shortage of healthcare workers [8]. At the individual level, low uptake and missed vaccinations have been associated with geographical location, financial constraints, lack of awareness, trust, and vaccine hesitancy [8,9,10,11]. Vaccine hesitancy, in particular, delays or prevents vaccination uptake. One of the“5 Cs” model proposed to tackle hesitancy included the importance of communication in addressing vaccine hesitancy (Confidence, Complacency, Convenience, Communication, and Context) [12]. Studies indicate that effective communication is essential to bridging the vaccination uptake gap, increasing awareness, and combating hesitancy, with evidence showing that ineffective vaccination communication contributes to incomplete or zero-dose vaccination for African children [13]. Previous studies employing the 5Cs framework in Africa have often used aversion that excludes communication but focuses on slightly different parameters (Confidence, Complacency, Constraints, Calculation, and Collective responsibility) [14]. However, these studies have identified that reasons for low vaccination rates were often associated with gaps in communication strategies used for conveying information about vaccines [15,16,17]. Limited communication channels and resources can further hinder the efforts to counteract negative information about vaccines and build community trust [18]. Conversely targeted effective communication, which provides easy-to-understand vaccine information and strong evidence, increases uptake [19]. This, in turn, provides both individual and population protection from vaccine-preventable diseases (VPDs), which have high transmissibility, morbidity, and mortality rates. Creating effective public health messages is therefore critical for improving vaccine uptake in Africa.Several vaccination programs have been implemented acrossAfrican countries to address infectious diseases [20,21]. However, existsing reviews of communication strategies have predominantly focused on human papillomavirus (HPV) vaccines [7,22]. Given the disruptions caused by the COVID-19 pandemic, it is imperative to reassess vaccination communication strategies across Africa in order to enhance uptake for a wider range of VPDs. This systematic review aims to summarise commonly adopted vaccination communication strategies across African countries and evaluate their influence on vaccine uptake, with the goal of improving vaccination coverage and public health protection. 2. Methodology The review protocol was pre-registered on the International Prospective Register of Systematic Reviews (PROSPERO ID: CRD42020196073) [23]. The review followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines [24]. We conducted a comprehensive search of peer-reviewed literature in consultation with a medical librarian. 2.1. Eligibility Criteria All population groups are at risk of vaccine-preventable infectious disease, so they were all considered in this review. The interventions of interest were vaccine communication strategies, acceptance, and uptake. The exposure of interest was the spread of vaccination education and information. Pre-defined eligibility criteria for inclusion included (i) research articles reporting vaccine communication and quantitative uptake evidence, (ii) studies conducted in African countries only, and (iii) studies published in English from 2020 to date. All study designs were included if they met the inclusion criteria. Exclusion criteria included systematic reviews, studies without quantitative outcomes related to vaccination communication (e.g., percentage of who engaged in the communication and vaccination uptake or coverage), and in vitro, non-human studies, non-English language publications, and studies not focused on African countries. 2.2. Search Strategy We searched the following databases from 2000 to October 2023: MEDLINE, EMBASE, CINAHAL, Scopus, and Web of Science, along with a free text search of the first ten pages of Google Scholar. Only English-language publications focused on African countries were considered. The search terms were based on a combination of keywords for three key concepts: “Vaccination” AND “Communication” AND “African countries”. Within each concept, keywords were combined with Boolean search operators (see Supplementary S1), and the reference lists of eligible studies were also searched to identify additional relevant studies. 2.3. Study Selection One reviewer carried out the literature search, and references were uploaded to the Rayyan review manager [25]. After the automatic removal of duplicates, the remaining studies were screened manually. All titles and abstracts were screened by two authors independently, and discrepancies were resolved through discussions with another author. References that met the inclusion criteria at the title and abstract screening stage then underwent full-text screening independently by two reviewers, and the reference lists of the included studies were also reviewed for additional relevant articles. 2.4. Study Appraisal Quality assessment was conducted using the Joanna Briggs Institute (JBI) checklist that matched the design of the included studies with one reviewer conducting the assessment and a second reviewer verifying it [26]. The JBI quality assessment does not involve assigning numerical scores to checklist components, so the grading decision in this review was subjective. If a criterion did not apply to a specific study type, it was marked as ‘not applicable’ and did not contribute to the final quality score. Studies were graded based on how well they met the assessment requirements: weak (0–39%), moderate (40–79%), and strong (80–100%). 2.5. Data Extraction Data from all included studies were extracted into Microsoft Excel. Key variables extracted included author(s), year, country, study population, design, vaccines administered, vaccination communication method, uptake, barriers, and facilitators. One reviewer performed the extraction, and another checked it for accuracy. Measures of effect extracted included proportions and confidence intervals, average means, standard deviations, prevalence ratios, and other applicable measures, as reported in the included studies. 2.6. Analysis and Narrative Synthesis Findings from the included studies were entered into tables and descriptively synthesised following the SWiM guideline [27]. The primary outcome assessed was the vaccination communication approaches and their associated changes in vaccination uptake. The secondary outcomes explored were barriers, facilitators, and other factors influencing vaccination decisions, as well as changes in attitude after exposure to information provided through the identified vaccination communication methods. Comparisons across the different countries were also assessed. The analysis explored the variation in the outcomes of interest, but a meta-analysis investigation was not conducted due to high heterogeneity in the reported effects. 3. Results 3.1. Results of the Search A total of 21,986 search results were identified from all data sources; 11,735 duplicates were removed, 10,251 titles and abstracts were screened, and 370 studies were identified for full text review(Figure 1). Finally, 41 studies were included in the review. PRISMA flow diagram of study inclusion. 3.2. Study Characteristics Table 1 presents a summary of the included publications. Fourteen African countries were represented: Nigeria (n = 15 studies), Ethiopia (n = 4), Ghana, Kenya, South Africa and Cameroon (n = 3 each), Malawi and Tanzania (n = 2 each), and one study from the Central Africa Republic, Egypt, Madagascar, Mali, Morocco, and Zimbabwe. The studies were conducted in three distinct settings: community (n = 23), health centres/clinics (n = 9), school (n = 7), and community and health centres (n = 2). A variety of study designs were adopted, including quasi-experiments (n = 18), cross-sectional (n = 6), randomised controlled trials (n = 9), and qualitative (n = 4) approaches. Additionally, there was also one article each of a documentary, program evaluation, government report, and commentary. The included studies were conducted between 2001 and 2023, with study durations ranging from 1 to 12 months (average = 5 months), with the longest durations found in the experimental studies [28,29,30,31]. The focus of the studies was mainly on vaccines for polio (n = 15 studies), human papillomavirus (HPV) (n = 9), Bacillus Calmette–Guérin (BCG) (n = 9), measles (n = 8), and COVID-19 (n = 6). Other vaccines included pentavalent vaccines (n = 5), diphtheria, tetanus, and pertussis (DPT) and Hepatitis B (n = 3 each); yellow fever, oral cholera, Pneumococcal conjugate vaccine (PCV) (n = 2 each), and one study each on tetanus toxoid and typhoid vaccine. The reviewed studies encompassed a wide range of age groups, from infants under one year to individuals over 75 years old, with most studies targeting children and adolescents. Engagement with these groups was often through their caregivers, particularly mothers [32,33,34]; while a few studies also involved fathers and teachers [35,36]. Studies on vaccines for adults were primarily targeted at womenwith other studies focusing on adults in general [37], conflict victims [38], health workers, policymakers, and leaders [34,39]. Most studies were assessed as moderate quality (strong =14, moderate = 24, weak = 2). The potential risk of bias was primarily related to the intervention component details, outcome reporting (e.g., response rates, measures used), and statistical methods (e.g., accounting for confounding factors). Given the significant heterogeneity across the included studies, an in-depth statistical analysis of the findings could not be conducted. Therefore, the findings should be interpreted with caution. Table 1Summary of vaccination communications and uptake in the included studies.AuthorCountry of StudyStudy Design/Study DurationVaccine AdministeredTarget Group/Sample SizeSettingVaccination Communication MethodVaccination UptakeQuality AssessmentAbd Elaziz et al. 2010 [40]EgyptQuasi-experimental2 monthsMeasles and rubella (MR) vaccineMedical students (n = 341)SchoolCampaign using posters Vaccine uptake: 65% StrongAddi et al. 2021 [41]MoroccoCross-sectional(DNR)COVID-19 vaccineGeneral population(n = NR)CommunityOfficial Ministry of Health website mass mediaVaccine coverage: 8.94%WeakAdmassie et al. 2009 [42]EthiopiaQuasi-experimental4 monthsDPT 3-dosesPolio 3-dosesBCG Measles Households(n = 3095)CommunityTraining of health extension workersHouse visitsFully vaccinated with BCG, polio, measles, and DPT vaccines is significantly larger in the treatment villagesModerateAkande et al. 2005 [43]GhanaCross-sectional1 monthPolio vaccineChildren aged 0–59 months (n = 3737)CommunityHouse visitsAnnouncements by radio and gong-gongMobile vanHealth worker’s educationVaccination uptake: 98.8%ModerateAmani et al. 2023 [44]Central African RepublicCross-sectional5 monthsCOVID-19 vaccineGeneral population(n = 5,570,659)CommunityCapacity building and training of CHWHealth education by trained CHWsVaccination coverage change: 9% to 29%ModerateAmani et al. 2021 [45]CameroonCross-sectional(Evaluation)1 monthOral cholera vaccine (OCV)General population (n = 537,274)Health centreHouse visits by social mobilisersMessages circulated through press, radio, sports, television, megaphones, banners, and postersThe overall vaccination coverage was 99.9%StrongAmare et al. 2021 [46]EthiopiaQuasi-experimental 7 monthsPenta-3Polio 3 vaccinesHealth workers(n = 90)Health centreCapacity building of health workers17.4% increase for Penta 3 vaccine in IG over CGModerateAndrianarivelo et al. 2001 [47]MadagascarQuasi-experiment(DNR)Oral polio vaccine (OPV)Children up to 59 months(n = 929)CommunityMass immunisation campaigns Vaccination coverage after two mass campaigns: -91.9% (113/123) children without a history of previous routine dose-83.3% (20/24) children with a history of 1 or 2 routine dose(s)-93.2% (150/161) children with 3 routine doses-96.3% (158/164) children with 4 routine doses ModerateAppiah et al. 2022 [48]EthiopiaRCT3 monthsPenta 3 vaccineMothers of children (n = 638)CommunityRadio Campaign:IG: 10 + 10 + 30(10 min radio drama on infant vaccination, 10 min discussion by CHW, 30 min phone-in from listeners)CG: No interventionCG = 324; IG = 314Vaccine coverage changeIG: 89.8%, 95% CI: 85.9–92.9%)CG: (65.1%, 95% CI: 59.7–70.3%).StrongAteudjieu et al. 2022 [37]CameroonCross-sectional2 monthsOral cholera vaccineGeneral population(n = 9212)CommunityTraining workshops for healthcare workersFirst round = 4372, second round = 4840Vaccination coverage- First round: 81.0%- Second round: 88.8%(single dose change 4.3%, second dose change 80.1%)StrongBangure et al. 2015 [49]ZimbabweRCT7 monthsChildhood immunisationWomen(n= 304)Health centreIG: Automated text reminders were sent at 6, 10, and 14 weeksCG: Routine health educationIG = 152, CG = 152Immunisation coverage - At 6 weeks: IG (97%) vs. CG (82%), (p < 0.001).- At 14 weeks: IG (95%), CG (75%)ModerateBasheer et al. 2021 [50]NigeriaQuasi-experiment4 monthsChildhood immunisationMothers of children 12–23 months of age (n = 420)CommunityTraining of primary HCWs to improve interpersonal communication skillsIG = 210, C = 210Routine childhood immunisation uptake (IG vs. CG)- Fully immunised: 53.8% vs. 9.5%- Partially immunised: 16.6% vs. 32.8%- Un-immunised: 29.5% vs. 57.6%p < 0.001.ModerateBotha et al. 2015 [51]South AfricaQuasi-experiment(DNR)HPV vaccineGirls(n = 2046)SchoolAdvocacy for school stakeholders and teachersHealth education targeted at caregivers and schoolgirlsWritten information leaflets- At least one dose of HPV vaccine: 99.2%- Received 3 doses: 87.8% - Sufficient vaccination: 91.6% of the vaccinated cohortModerateBrown et al. 2016 [39]NigeriaRCT(DNR)Childhood immunisationChildren aged 0–12 months paired with their mothers (n = 595)Health centreCell phone call reminderPrimary healthcare immunization Providers’ training interventionImmunisation completion:- IG (3 arms): cell phone reminder (98.6%), PHC providers’ training intervention (70%), combined cell phone reminders and training of PHC providers (97.3%)- CG: 57.3%ModerateCrippin et al. 2022 [52]MaliQuasi-experiment7 monthsHPV vaccineWomen(n = 500)Community and health centreCommunity educational sessions by community health workers and a storytelling clothWillingness of women to want their children to be vaccinated: 87%ModerateDougherty et al. 2020 [29]NigeriaQuasi-experiment12 monthsBCGPolio vaccineHep B vaccineChildren aged 0–23 months and their mothers (n = 2639)CommunityTraining of traditional barbers (direct and interpersonal communication)Received yellow card: IG (16.6%)ModerateDreyer et al. 2015 [32]South AfricaQuasi-experiment(DNR)HPV vaccinePrimary school girls; parents and female guardians (n = 3465)SchoolHealth education with presentation and leafletsVaccination uptake- First dose: 99.3%- Second-doses: 95.9% (974/1016)- Third-dose: 91.6% (1859/2030).- Overall completion: 90.5%ModerateDurrheim et al. 2001 [53]South AfricaCommentary(DNR)Polio vaccineMeasles vaccineChildren(n = NR)CommunityMass immunisation campaigns- Decrease in second-round national OPV coverage by: 1995 (11.7%), 1996 (12.8%), 1997 (3.5%)- Polio mass campaign coverage declined by 7.7% between 1995 and 1997 (chi-square for trend = 7465.3, df =1, p < 0.001)- Measles Campaign: 1996 (91.1%) and the 2000 campaign (91.0%)WeakEgbon et al. 2022 [54]NigeriaCross-sectional5 monthsHPV vaccineSchool girls 9–19 years old(n = 100)SchoolCommunity mobilisation and advocacyVaccination completion: under-14 years (60%, 42/70), ≥15 years 83% (25/30)StrongEkhaguere et al. 2019 [28]NigeriaRCT12 monthsPenta 1, 2, 3 vaccineMothers of children(n = 600)Health centreAutomate reminders using phone calls and text messagesIG (n = 300), CG (n = 300)Completion of 12-month immunisation series:IG (74%) vs. CG (66%); (RR: 1.12, 95%CI: 1.01–1.25; p = 0.03)Received Penta-3 within 1 week of the expected date: IG (84%) vs. CG (78%); (RR: 1.09, 95%CI: 1.01–1.17, p = 0.04)Received measles immunisation within 1 week of the expected date: IG (73%) vs. CG (65%); (RR: 1.33, 95%CI: 1.02–1.26, p = 0.02)StrongGibson et al. 2017 [31]KenyaRCT12 monthsPentavalent and Measles vaccineCaregivers of infants aged 0–34 days(n = 2018)CommunityIG1 = SMS only(Financial incentives)IG2 = SMS + 75 KESIG3 = SMS + 200 KESIG1 (n = 476), IG2 (n = 562), IG3 (n = 491), CG (n = 489)- Full immunisation among children 12 months of age:- IG (3 arms): SMS only (86%), SMS + 75 KES (86%), SMS + 200 KES (90%)- CG: 82%- Coverage at 12 months and timely vaccination:- IG (3 arms): SMS only (48%), SMS + 75 KES (60%), SMS + 200 KES (62%)- CG: 41%ModerateJones and Kawesa-Newell, 2021 [55]MalawiQuasi-experiment(DNR)HPV vaccineSchool girls(n = NR)SchoolMini magazineVaccine uptake change- Cohort 1: 83% vs. 70%, p = 0.0028- Cohort 2: 82% vs. 62%, p = 0.0002ModerateKaduru et al. 2023 [33]NigeriaQuasi-experiment5 monthsChildhood immunisationCaregivers (women) (n = 216)CommunityCommunity drama/theatreFully immunised: Baseline (46%), midline (55%), post-intervention (84%)StrongLevine et al. 2021 [56]GhanaRCT5 monthsPolio vaccineBCG vaccineMothers who delivered a live-born, surviving infant; primary caregivers(n = NR)CommunityIG1 = Voice call remindersIG2 = Community health volunteers and financial incentives (training of community health volunteers)Vaccination coverage- First dose of Polio and BCG: higher in all arms than during the baseline period- Vaccinated on time with both vaccines: voice call reminder (37.8%), CHV and incentives arms (54.5%)- Increase from pre-intervention to post-intervention: voice call reminder (12.8% points), CHV and incentives arms (42.0% points)ModerateMeiring et al. 2019 [57]MalawiQuasi-experiment3 monthsTyphoid conjugate vaccineCommunity members(n = NR)SchoolCommunity mobilisation and advocacyAnnouncements and jingle for invitation for vaccination with a mobile vanSchool-based vaccine campaign increased community participation, exceeding recruitment targets (average, >200 children/day) Mekonnen et al. 2021 [30]EthiopiaRCT12 monthsPenta 3MeaslesMothers and infant(n = 434)Health centreIG = Text message remindersCG = Routine verbal remindersIG = 217, CG = 217- On-time vaccination: IG (63.3%), CG (39.9%)- Penta 2 coverage: IG (98.1%), CG (95.3%)- Penta 3 coverage: IG (95.8%), CG 185 (86.9%)- Measles vaccine coverage: IG (91.5%), CG (79.3%)StrongMohammed et al. 2023 [58]GhanaCross-sectional(DNR)COVID-19 vaccineHCWs(n = 424)Health centreMediaFirst dose of COVID-19 vaccine uptake: 73.6%ModerateMphuru et al. 2022 [59]TanzaniaQualitative2 monthsHPV vaccine14-year-old girls (n = 10)Community and Health centreHealth education in schoolsCommunity advocacy and sensitisationMass media using posters, brochures, fliers, TV, radio, social media- First dose (HPV1) coverage: 78%- Second dose (HPV2) coverage: 49%.StrongMsunyaro et al. 2023 [60]TanzaniaQuasi-experiment8 monthsCOVID-19 vaccineCommunity members (n = 1,351,320)CommunityCommunity engagement; house visits, village meetings by community championsIncrease during the campaign: 10% to 22%ModerateObi-Jeff et al. 2022 [34]NigeriaQualitative(DNR)Routine childhood immunisation (BCG, OPV, DPT, Hep B, Measles, Yellow fever vaccines)Program stakeholders (policymakers, program managers, development partners) and HCW(n = 144)CommunityAutomated text messages using immunisation reminders systemMany noted that personalised reminders reminded caregivers, especially those who were busy and forgot their child’s vaccination dates and prompted them to go for vaccinationModerateOdunyemi et al. 2018 [61]NigeriaQuasi-experiment(DNR)HPV vaccineMarried civil servants’ women(n = 146)CommunityIG = Health education by nursesCG = No interventionIG = 69, CG = 77Mothers were ready to accept HPV vaccination for their adolescent daughters- Baseline: IG (73.9%), CG% (83.1%) - 3-months: IG (93.8%), CG% (60.8%) StrongOku et al. 2017 [62]NigeriaQualitative2 monthsChildhood immunisationCaregivers and Healthcare workers(n = 84)CommunityHealth workers education Mass media (radio and jingles)Town announcers in churchHome visitsAll caregivers:-Expressed messages received in the clinic were useful-Received information about managing vaccination side effectsModerateOzohu-Suleiman et al. 2010 [63]NigeriaCross-sectional(DNR)Polio vaccineCommunity members, including caregivers (n = 2253)CommunityMass immunisation campaigns using interpersonal sources- Immunisation campaign acceptance: 5.1% - Immunisation campaign resistance: 44.9%ModerateSato and Takasaki, 2021 [64]NigeriaRCT2 monthsTetanus toxoid vaccinePregnant women/women with children(n = 1600)CommunityGraphical illustrations using flipchartsIG = 782Decreased vaccine take-up by 3.7–6.1%StrongSato and Titus, 2021 [65]NigeriaQuasi-experiment10 monthsChildhood immunisationWomen with children(n = 515)CommunityIG = One-time tailored information on their children’s current vaccination status and the next schedule for vaccinationCG = Generic information on the vaccination scheduleIG = 198, CG = 317Immunisation uptake: IG (38.4%), CG (46.6%)StrongUgwuoke et al. 2021 [38]NigeriaQuasi-experiment(DNR)COVID-19 vaccineVictims of conflicts in IDPS(n = 470)CommunityIG = Graphical illustrations using visual illustrations on the importance of COVID-19 vaccination and counsellingCG = No interventionIG = 235, CG = 235Intention toward COVID-19 vaccination (pre vs. post-test) (mean, SD): IG (1.1, 0.21) vs. (3.8, 0.98), CG (1.2, 0.11 vs. 1.3, vs. 0.23)ModerateVermandere et al. 2015 [35]KenyaQualitative2 monthsHPV vaccineTeachers and parents of girls(n = 7)SchoolTraining of teachers by HCWs Health education to create awareness for girls and fathersTeachers = 4, Fathers = 3Despite high baseline acceptance, reported uptake at follow up was lowModerateWamai et al. 2012 [66]CameroonCross-sectional2 monthsHPV vaccineParents of girls aged between 9–13 years old(n = 337)CommunitySensitisation campaigns conducted through local media using both radio and televisionOverall to vaccinate daughters: 49.9% Strong willingness to vaccinate: 27.0%StrongWarigon et al. 2016 [67]NigeriaQuasi-experiment(DNR)Polio vaccineChildren(n = 5991)CommunityAdvocacy for religious leader supportLocal dramaMedia, radio, newspapers. and TVReceived vaccination: 85.5%ModerateYau et al. 2023 [68]NigeriaQuasi-experiment(DNR)Routine childhood immunisation (BCG, OPV, DPT, Hep B, Measles, Yellow fever) vaccinesNewborns (0–14 days old) and mothers(n = 435)Health centreIG = Color-coded braceletsCG = No bracelets, but they received standard information provided at routine immunisation servicesIG = 256, CG = 179Completed their vaccination schedule at the fifth contact: IG (62%), CG (41%), p < 0.0001ModerateYego et al. 2023 [36]KenyaRCT(DNR)COVID-19 vaccineHigh-risk patients either due to age (>60 years old) and/or have a documented medical history of hypertension or diabetes(n = 8514)Health centreIG1 = Phone call + Gain messagesIG2 = Phone call + Loss messagesIG3 = Phone call + Social norms messagesIG4 = SMS + Gain messagesIG5 = SMS + Loss messagesIG6 = SMS + Social norms messagesCG = No interventionIG1 = 1216, IG2 = 1216, IG3 = 1216, IG4 = 1216, IG5 = 1216, IG6 = 1217CG = 12171716 (47%) participants in the phone call channel received interventionVaccination status of those who received the intervention: 83% (1524)- Completed vaccine doses: 89% (1267) - Partially vaccinated: 11% (157) had beenStrongNOTE: BCG = Bacillus Calmette–Guérin, CG = control group, CHW = community healthcare workers, DNR = duration not reported, DPT = diphtheria, tetanus, and pertussis, HCWs = healthcare workers, Hep B = hepatitis B, HPV = human papillomavirus, IG = intervention group, OCV = oral cholera vaccine, RCT = randomized controlled trial RR = relative risk, VPD = vaccine-preventable disease. Summary of vaccination communications and uptake in the included studies. -91.9% (113/123) children without a history of previous routine dose 91.9% (113/123) children without a history of previous routine dose -83.3% (20/24) children with a history of 1 or 2 routine dose(s) 83.3% (20/24) children with a history of 1 or 2 routine dose(s) -93.2% (150/161) children with 3 routine doses 93.2% (150/161) children with 3 routine doses -96.3% (158/164) children with 4 routine doses 96.3% (158/164) children with 4 routine doses NOTE: BCG = Bacillus Calmette–Guérin, CG = control group, CHW = community healthcare workers, DNR = duration not reported, DPT = diphtheria, tetanus, and pertussis, HCWs = healthcare workers, Hep B = hepatitis B, HPV = human papillomavirus, IG = intervention group, OCV = oral cholera vaccine, RCT = randomized controlled trial RR = relative risk, VPD = vaccine-preventable disease. 3.3. Study Findings 3.3.1. Vaccination Communication Methods Most studies used multiple vaccination communication methods, especially mass vaccination campaigns [47,53,63]. The verbal communication mediums included radios [43,45,48,59,62,66,67], television broadcasts [45,59,66,67], and social media [59]. Direct verbal communication was also utilised through home visits, social mobilisers, community mobilisation, announcements, and advocacy [43,44,51,54,57,59,62,67]. Seven studies used information from print media, such as newspapers [67], posters [40,45,47,59], flyers and leaflets [51], and magazines [55]. Two studies used graphical illustrations as a communication method for vaccination [38,64]. Automated reminders to get vaccinations were also used through text messages [28,30,31,34,36,49], phone calls [28,39,56], or a combination of both [28,36]. Health education was the key element of most vaccination communication [32,49,51,52,59,61]. This also included capacity building and training of healthcare and vaccination providers to improve interpersonal communication [35,37,39,42,43,44,45,46,50,56] and education for other groups, including other community members, such as traditional barbers and caregivers [29,35,51]. Community engagement approaches used included advocacy with stakeholders [51,54,57,59,67], house visits [42,43,44,45,60,62], and social mobilisation [44,45]. Other methods used to spread vaccination information included using community drama to share vaccination messages through entertainment [33,67] and using a five-colour-coded bracelet representing different immunisation contacts given to newborns [68]. Open-door announcements around the communities were an integral part of disseminating vaccination-related information [43,57]. 3.3.2. Vaccination Communication Sources and Purposes The information included in the vaccination communication was from various contributors. However, the most common sources were the national Ministries of Health [30,37,40,41,44,45,50,54,59]. Non-governmental organisations (NGOs), foundations, and trusts were also significant information sources [45,52,54,55,57]. On a broader scale, journalists and media outlets were essential in shaping public perception [45,67]. The role of the media was underscored by studies [38,47,58,62,63], research teams [28,46] and wider sub-national public health and surveillance sectors also played a role in vaccination communication [31,45,51,54,57]. Training manuals and recommendations from organisations like the World Health Organization (WHO), the Centers for Disease Control and Prevention (CDC), etc., were critical resources for developing communication strategies and resources [31,35,39,59,68]. The purpose of most vaccination communication was to inform and educate the public about either the disease targeted by the vaccine and/or the vaccine itself [29,32,33,41,43,45,48,51,52,54,56,57,58,60,61,62,64,66,67]. Another commonly reported communication aim was to ensure timely vaccination compliance using the reminder system [28,30,31,39,40,49]. Developing and enhancing vaccine providers’ skills were recognised as a crucial reason for implementing vaccination communication training [37,44,46]. Some vaccination communication efforts were implemented to improve vaccine uptake and acceptance [38,45,50,55,59], including encouraging caregivers to vaccinate their children [29,36]. In one study, three distinct messaging strategies—gain messaging, loss messaging, and social proofing—were used via phone calls or text messages to promote vaccination among high-risk populations [36]. 3.4. Vaccination Coverage and Uptake Overall, vaccination coverage and uptake increased after the implementation of the vaccination communication interventions in all countries. In Nigeria, most studies showed a clear increase in vaccination coverage [28,29,33,34,39,50,54,63,68]. A cross-sectional study on HPV community mobilisation and advocacy showed that 60% (42/70) of girls under 14 and 83% (25/30) aged 15 and older completed their vaccinations [44]. Another study aimed at newborn identification and referral by traditional barbers reported a 16.6% increase in the number of individuals in the intervention group who received a yellow card at the end of the study [29]. Conversely, Sato and Takasaki reported a decline in vaccine uptake by up to 6.1% despite increased participants’ perceived risk of disease after viewing graphical illustrations of the tetanus toxoid vaccine [64]. Some other studies also showed no significant change in vaccine coverage rates after the communication intervention [38,65]. All four studies in Ethiopia showed increased vaccination coverage [30,42,46,48]. The two intervention studies for Penta-3 vaccines showed a significant increase in vaccination coverage [46,48]. The uptake after a radio campaign was 89.8% compared with 65.1% in the non-intervention group and 17% higher in the Penta-3 vaccine after health worker capacity building in the intervention group compared with the non-control group [48]. Another study reported a significantly higher proportion of children getting fully vaccinated with BCG, polio, measles, and DPT after trained health extension workers paid home visits [42]. The three studies in Kenya also reported significant vaccine uptake changes [31,35,36]. Gibson et al. reported that 86% of children successfully followed up for pentavalent and measles vaccines were fully vaccinated [31]. Similarly, another study reported an 83% increase in COVID-19 vaccine coverage [36]. In contrast, another study reported low vaccine uptake at follow-up [35]. All studies conducted in Ghana showed an increase in vaccine coverage [43,56,58]. For example, Mohammed et al. reported a 73.6% uptake of the COVID-19 vaccine’s first dose after a media intervention in health centres [58]. Two studies in Cameroon indicated a high vaccination coverage against cholera. Amani et al. reported an overall vaccination coverage of 99.9% after a mass vaccination campaign against cholera [45]. Another study in Cameroon observed a significant 8% rise in oral cholera vaccination coverage, with rates increasing from 81.0% in the first round of the vaccination campaign to 88.8% in the second round, following the training of vaccination providers during the program’s monitoring and evaluation process [37]. However, a study by Wamai et al. showed a low willingness to be vaccinated against HPV in Cameroon among parents of girls aged between 9 and 13 years old (49.0%) [66]. The study in Zimbabwe showed an increase in vaccine uptake among children of mothers who received SMS reminders compared with children of mothers who did not [49]. The immunisation coverage at six weeks was 97% in the intervention group and 82% in the non-intervention group (p < 0.001) [49]. Similarly, the study in the Central Africa Republic showed that COVID-19 vaccine coverage tripled from 9% to 29% with the capacity-building of community health workers and other communication efforts [44]. The single study for Mali showed that the willingness of women to vaccinate against HPV increased to 93% after a community education campaign [52]. Also, a study in Egypt reported a moderate vaccination uptake of 64.8% after a poster campaign targeted medical students against measles and rubella [40]. The study in Madagascar reported that overall seroprevalences for all poliovirus types increased significantly among the children after the mass campaign: 78.2% vs. 94.3% for poliovirus type 1, 86.0% vs. 98.5% for poliovirus type 2, and 69.1% vs. 89.8% for poliovirus type 3 [47]. The Tanzania study showed coverage of the first dose of HPV vaccine (HPV1) at the end of 2019 was 78%, and the second dose of HPV vaccine (HPV2) coverage was 49% [59]. A rapid COVID-19 vaccine coverage reported a 12% increase (from 10% to 22%) in the number of people vaccinated after the community engagement campaign [60]. In contrast, the reported COVID-19 vaccine coverage in Morocco was relatively lower at 8.94%, even after an official mass media campaign by the Ministry of Health website [41]. Two studies in South Africa showed an increase in HPV vaccination [32,51]. One study reported an overall completion rate of 90.5%, with 99.3% of consented girls receiving the first dose of the vaccine [32]. Among those vaccinated, a higher proportion received the two-dose regimen (95.9%) than the three-dose regimen (91.6%) [32]. Likewise, Botha et al. showed that 91.6% of the girls in the vaccinated cohort achieved adequate vaccination coverage [51]. This is in contrast to the other studies by Ogunbanjo et al. in South Africa that reported a decrease in vaccination coverage for the polio and measles vaccine [53]. Findings from the two studies in Malawi were in a school setting. One study reported that girls exposed to the HPV vaccination communication had a higher vaccine uptake after reading Zathu mini magazine and were significantly more likely to have had their allocated doses of the HPV vaccine than those who had not (83% vs. 70%) [55]. The school-based vaccine campaign increased community uptake, exceeding recruitment targets to date (on average, >200 children/day) [57]. 3.5. Barriers and Facilitators to Vaccine Uptake Various barriers and facilitators to vaccination communication intervention and general vaccine uptake were identified in the included studies (see Table 2). In relation to the communication methods used, Bangure et al. stated that the overall increase in vaccine uptake was likely attributed to the use of SMS reminders [49]. Hence, a population with no access to mobile phones with the required features needed to deliver the intervention will not be able to benefit effectively from such intervention, as indicated in another study that stated lack of mobile phones and inability to read text messages were barriers to intervention participation [34]. These factors highlight the importance of compatibility and operability in vaccination communication delivery. General barriers to vaccination compliance included a combination of facility and population factors. For instance, Ekhaguere et al. reported barriers to childhood immunisation uptake, including long waiting times, distance to a clinic, transportation costs, inconducive clinic sites, and mother’s forgetfulness [37]. The clinic environment, long waiting times, and health worker attitudes were also reported in other studies as obstacles to receiving vaccination information [62]. The health workers’ attitudes were affected by poor communication skills, lack of motivation, and community, including vaccine resistance attitudes [63]. Such vaccine hesitancy was reported as a significant barrier to uptake [41,69]. The primary barriers identified in the first round of vaccines with multiple doses were often related to low awareness and the absence of children [37,56]. Concerns about vaccine safety were particularly affecting COVID-19 vaccine acceptance and uptake [58,60]. Fear of vaccine effectiveness, lack of trust in vaccines, potential side effects, vaccine safety, lack of information regarding vaccine and venue and cost were barriers to HPV vaccine uptake [35,61,66]. One study in Nigeria showed low literacy as a barrier to vaccination uptake among community members [29], and another study reported controversial religious theories about vaccines that affected polio vaccine uptake [59,63]. Similarly, several studies reported a lack of appropriate information and misinformation as a significant barrier affecting vaccine uptake [37,40,48,59,61,67]. Facilitators to vaccine uptake included increased vaccine knowledge using acceptable information [34,40,66], free vaccination [41,58], health staff task shifting for improving equitable vaccine access [44], vaccination reminders, e.g., using text messages [31] and providing incentives for both vaccine administrators and community members [56]. Increased knowledge of vaccine was observed to be both a facilitator and barrier, as shown in two studies that reported awareness of the protective effect of HPV increased willingness for vaccination, but also information of possible dangers generated fear that the vaccine harms the fertility of girls [34,66] Quantitative evidence of the positive and negative factors that influence vaccination uptake, even among health professionals, were observed in a study in Ghana, which found that factors motivating respondents to receive the COVID-19 vaccine included its lack of cost (82.7%), perceived efficacy, and safety (75.6%), protection against the virus (70.8%), the sense of social responsibility (61.9%), benefits outweighing the risks (72.1%), absence of harm (62.2%), and observing others getting vaccinated (62.2%) [58]. Table 2Summary of vaccination facilitators, barriers, accessibility, availability, and service gaps.Author, Year FacilitatorsBarriersAbd Elaziz et al. 2010 [40]More health educationInsufficient information, fear of getting infection, past infection, unconcerned, afraid of injections, vaccinated in private, fear of side effects, othersAddi et al. 2021 [41]Vaccination campaign is free for all citizens and foreigners Fake news in social media, low level of education and economic status, and insufficiency in population awareness programsAmani et al. 2023 [44]Task shifting provided equitable vaccine access Andrianarivelo et al. 2001 [47]OPV doses during the mass vaccination campaign improved their immune status Appiah et al. 2022 [48] Lack of communication and knowledge about the importance of vaccinationsAteudjieu et al. 2022 [37] Absenteeism (49.4%), Lack of awareness (18.2%) Bangure et al. 2015 [49]Overall increase likely attributed to use of SMS reminders Crippin et al. 2022 [52] Seeking consent from husband or partner firstDougherty et al. 2020 [29]Parents trusted traditional barbers; messages shared consistently throughout the community reinforced their beliefs that the advice benefited child healthLow levels of literacy among community leaders and barbersEgbon et al. 2022 [54] Remote area, hard-to-reach locations, high operational costs, infrastructure health workforce, vaccine delivery included operational costs exacerbated by a lack of adequate health workforce and infrastructureEkhaguere et al. 2019 [28] Long wait times (55%), transportation cost (34%), distance to the clinic (4%), forgetfulness (2.2%), clinic not conducive for mother and child (2%)Gibson et al. 2017 [31]SMS reminders plus monetary incentives were modestly effective Jones and Kawesa-Newell, 2021 [55]Girls interest in reading the Zathu mini magazine as they were already familiar with the characters and believed the Zathu brand to be trustworthy and reliable Levine et al. 2021 [56]- Vaccination provided by a community-level health system infrastructure- Incentives to both CHV and caregivers Timely vaccination and complete birth registration are not remunerated and formally cadred Mohammed et al. 2023 [58]COVID-19 vaccine, vaccine-free (82.7%), sufficient efficacy and safety (75.6%), protects against the virus (70.8%), social responsibility (61.9%), benefits outweigh the dangers (72.1%), does not harm people (62.2%), seeing others taking it (62.2%) Vaccine rapid development and approval (41.0%), immediate side effects (39.2%), unforeseen future effects (37.5%), health workers refusing to take the COVID-19 vaccine (24.5%)Mphuru et al. 2022 [59] Misinformation, religious radio station airing HPV vaccine causes infertilityMsunyaro et al. 2023 [60] Vaccine safety concerns Frequent changes in COVID-19 vaccine types confusingObi-Jeff et al. 2022 [34]- Perceived importance in reminding and educating community members on the importance of immunisation- Satisfaction with the message content, especially the health facility day and operation time accuracyLack of mobile phones and the inability to read text messages as barriers to intervention participationOdunyemi et al. 2018 [61] Lack of information deterred vaccinating daughters (85.5%), under age for vaccination, unaware of the venue of vaccination, cost of vaccineOku et al. 2017 [62] - Barriers affecting public: clinic environment, long waiting times, health worker attitudes- Barriers affecting health workers: poor communication skills, poor motivation, and attitudes of community members, including vaccine resistanceOzohu-Suleiman et al. 2010 [63] Fears of polio vaccine contamination with anti-fertility hormone and HIV virus aimed at depopulating Muslims around the world Vermandere et al. 2015 [35]Protecting girls fertilityBad experiences or rumours about other vaccines (polio and asthma especially) indicating possible danger of vaccines; new vaccine was potentially hidden experiment; fear vaccine harm girls fertility; fear vaccination will enhance sexual activity among childrenWamai et al. 2012 [66]Knowledge of HPVConcerns about vaccine effectiveness (31.8%) and side effects/safety (18.4%)Warigon et al. 2016 [67] Negative campaigns against polio vaccine in the media; negative campaigns initiated by scholars and religious leaders through various media platforms persuading audiences who were largely nonliterate vaccines were contaminatedYego et al. 2023 [36] No communication access via phone calls due to incorrect number and change in SIM Summary of vaccination facilitators, barriers, accessibility, availability, and service gaps. 3.6. Vaccine Accessibility and Availability Availability and accessibility of vaccination communication and services were not reported in most studies. The most common systemic reasons for vaccination attempts failing were vaccines not being available or stocked out or health providers refusing to open vials out of fear of wastage [56]. Also, hesitancy was higher when vaccination centres were too far and thus not easily accessible [37,47]. In contrast, where vaccines were readily available, e.g., for HPV, in addition to mass campaigns, increased potential for maximum vaccine coverage, as highlighted in Nigeria and Cameroon [37,61]. 4. Discussion To the best of our knowledge, this is the first study to present a systematic review of the communication strategies implemented to improve the uptake of a broad spectrum of vaccinations in Africa. The included studies represented 14 African countries, with several communications for children and adolescent vaccinations, particularly polio, HPV, and BCG. The identified adult vaccines were predominantly for mothers and COVID-19. Communication targeted at health workers aimed to improve their interpersonal communication skills with patients. Mass vaccination campaigns were the most common communication method, and other direct (e.g., home visits and text reminders) and indirect (e.g., training of community leaders who educated their communities) approaches were used. Community engagement was an essential part of indirect communication approaches. National health departments were the primary sources of the information; also, a few NGO interventions were identified, and both sources were guided by international vaccination guidelines. Vaccination coverage and uptake overall increased after exposure to the vaccination communication interventions in all the countries. However, factors like trust, vaccine availability, and accessibility significantly affected uptake. Barriers to uptake included lack of vaccine knowledge, vaccination services, distance to health centres, and vaccine costs at an individual and health system level. These factors contributed to high levels of vaccine hesitancy. In contrast, factors that improved uptake included increased vaccine knowledge, free vaccine services, and vaccination reminders. The identified predominant vaccine focus aligned with a recent review study that highlighted the resurgence of VPDs, particularly polio, despite efforts to control them [70]. The significant barriers to vaccine uptake were a lack of awareness and information about vaccinations and concerns about potential side effects. Lack of vaccination knowledge is a crucial factor influencing vaccination in Africa [6], but this is also a significant issue among similar populations in other regions such as Europe [71]. Thus, this review points out the importance and potential of vaccine communication. However, the limited number of countries represented highlights the gap in African vaccination communication evidence. Similar limited country representation has also been observed in other review studies investigating vaccination in Africa [6,7]. Our review showed that the critical source of vaccination information communication is the national health departments; hence, countries need to invest in national-scale vaccination communication plans to improve population awareness, uptake, and sustained vaccine delivery, especially routine vaccinations for children and mothers, as well as new vaccines developed to tackle emerging and re-emerging diseases such as COVID-19. This finding supports other evidence that has shown populations expect national institutions to be responsible for fact-checking and verifying vaccination information [72]. Having adequate knowledge improves precautionary and vaccine uptake behaviour; hence, targeted and clear messaging on the protection that vaccines afford to personal health could motivate uptake and practices [73]. Although mass campaigns were the most common communication strategy, there was no clear evidence of the most effective type of campaign. Social media platforms were another medium of interest, but only limited studies showed this. Interpersonal relationships and word-of-mouth from both health workers and community leaders were also significant determinants of vaccination uptake, similar to another review in Africa [6,7,74]. The observed community mobilisation approaches were effective in reaching and engaging diverse communities due to the influence these groups of people have on the community members; thus, communication support and training are required for such nonexpert messengers [74]. Our findings also showed that in all countries, most people were willing to get vaccinated as a result of all forms of communication, and people were open to reminders and nudges to facilitate vaccination uptake. Overall, vaccination acceptance and uptake are likely to be enhanced through multichannel communication [19,75]. Thus, implementing well-designed vaccination communication strategies and interventions, such as the creative and innovative measures identified, e.g., the use of automated reminders, drama, town announcers, etc., could help increase overall vaccination coverage. For instance, Indigenous communication media such as town criers can be used in rural African communities [76], radio drama increases vaccination awareness and knowledge [77], while new media such as text messages, electronic reminders, and immunisation campaign websites have been extensively noted to increase immunisation coverage rates [77,78,79,80]. Adapting such nudge-based interventions is necessary to appropriately adapt how information is framed and delivered to intended audiences [81]. Childhood immunisation and some maternal vaccinations were the common vaccine focus, showing gaps in communication for adult vaccines. The lack of communication for adult vaccines could influence their perceptions of the importance of vaccines for children, especially adolescent girls [6,82]. Interactive communications with parents through workshops and presentations led by medical professionals and health workers were effective in boosting vaccination, similar to findings from other studies [6,83]. Also, evidence has shown a positive association between interactive social mobilisation and first-dose coverage [83]. Thus, supporting existing communication around routine and new vaccine recommendations would improve vaccine uptake [83,84]. Targeting all stakeholders involved in vaccination delivery, communication, decision-making, and acceptance is essential for achieving maximum vaccine uptake and completion rates. As recommended in the ‘Ten actions towards vaccination for all’, healthcare professionals and the media also need to be empowered to provide effective, transparent, and objective information to the public and fight false and misleading information [85]. Hence, a communication strategy incorporating appropriate and available communication tools should be part of every immunisation program [7]. One essential tool is healthcare workers, who are considered the most trusted expert messengers [74]. Thus, providing communication training to improve their interpersonal communication skills with patients is critical to help them become more assertive while practising shared decision-making and deliberation with their patients [22,86]. Other communication tools, including mobile phones, are used for message reminders. However, devices need to be available, compatible, and operable by users to avoid disengagement [34]. To ensure broader engagement, it is necessary to deliver information through various sources, target different groups, and provide tailored messages from the outset to address concerns, especially about experimental vaccines and their effects on other issues, such as fertility, to pre-emptively counter rumours and misinformation that negatively influence vaccination programs [72]. Such targeted, effective communication addresses most factors influencing vaccine hesitancy [74,87]. Previous studies have shown that public health communication has different engagement levels, which all carry potential risks, benefits, and challenges when embracing social components [88]. Improving communication will not be impactful without adequate vaccine availability. Beyond awareness and increased knowledge through vaccination communication, shortages in vaccine supplies and accessibility of vaccination sites significantly contribute to low vaccine coverage. Similar to other reviews, access to and experiences of vaccination services, including undesirable features of vaccination services, long waiting times at healthcare centres, and cost implications, influenced vaccination decisions and practices in Africa [6,89]. The review by Mavundza et al. articulates suggested questions to consider when planning and implementing interventions to reduce vaccine hesitancy and increase vaccine acceptance and uptake in Africa [6]. 4.1. Implication of Findings The findings from this review indicate that various communication strategies have been implemented across Africa and that appropriate vaccine communication activities can significantly improve vaccine coverage. However, there is a gap in vaccine communication evidence across the entire region, with the limited number of countries represented. Thus, all countries need to be more proactive in the development, implementation, and reporting of vaccine communication strategies. To overcome barriers like vaccine hesitancy, such communication needs to clearly outline the benefits and risks of vaccines so as to tackle concerns that encourage hesitancy. Embedding communication plans in immunisation programs, such as activities identified in this review for both the public and health workers, will boost acceptance and uptake. Using multiple communication channels and combinations, especially through community networks, will enhance the impact across multiple audiences. Vaccine uptake also depends upon national guidelines, healthcare workers, and supplies, and these factors need to be considered before any vaccination communication intervention is launched. Thus, addressing logistical challenges at a national level, such as the availability of vaccines and competent staff, distance to facilities, and vaccine cost, would help reduce the broader barriers to vaccination. Our findings can, therefore, help inform strategies that national vaccination campaigns may consider to improve vaccinations in Africa. 4.2. Strengths and Limitations A key strength of this review is that the search was conducted to assess a wide range of vaccine-preventable diseases among various disadvantaged groups in all African countries to provide a broader assessment beyond the different countries. Considering that only 14 countries were represented, this may limit the generalisability of the findings across the continent. Our findings were also in line with other publications while highlighting significant gaps in the current body of evidence in Africa. The review was limited to peer-reviewed English-language publications only; hence, we may have missed some other relevant literature. Therefore, the data may be subject to publication bias. Grey literature that may have had relevant and interesting information was also excluded. Wide variations in study aims, intervention approaches, and countries reported made performing extensive comparisons and in-depth statistical analyses challenging. Several included studies employed multiple communication methods and sources, but most did not directly measure their individual impact on vaccination uptake and coverage, making it challenging to draw definitive conclusions about their effectiveness. More qualitative and quantitative research is required to investigate vaccine communication across different groups and countries in Africa to understand current communication strategies further and develop tailored vaccine communication intervention strategies for different populations and vaccines. Additionally, more innovative and improved vaccination communication services need to be developed for populations in Africa and beyond. 5. Conclusions Our study underscores the significant impact of communication strategies on vaccine uptake in African countries. Findings from this review highlight the effectiveness of various approaches in increasing vaccination coverage across diverse populations. Systemic barriers, including inadequate vaccine knowledge, challenges with logistics, and vaccine hesitancy, were identified as major obstacles to effective immunisation. However, facilitators such as education, reminders, and accessible vaccination services showed substantial potential in improving vaccine acceptance and compliance. Findings from this systematic review provide a roadmap for public health campaigns to improve vaccine coverage and support Africa’s progress toward global immunisation targets. Supplementary Materials The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/vaccines12121333/s1, S1: OVID Medline review search. Author Contributions Conceptualisation, W.E. and G.B.; Methodology, W.E. and G.B.; Validation, W.E. and B.I.; Data Curation, W.E., B.I. and J.V.; Formal Analysis, W.E., B.I. and J.V.; Investigation, W.E.; Resources, W.E.; Writing—Original Draft Preparation, W.E., B.I. and J.V.; Writing Review & Editing, W.E., B.I., A.B., B.O.U.-K. and I.I.; Supervision, W.E.; Project Administration, W.E. All authors have read and agreed to the published version of the manuscript. Conflicts of Interest All authors declare no conflicts of interest. Funding Statement This research received no external funding. Footnotes Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. References Associated Data Supplementary Materials